Evidence map›Paper›PMID 32454043›Full record

ArticleChest2020

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models.

Faisal Kamal, Nicholas Glanville, Wangmingyu Xia, Eteri Bakhsoliani, Julia Aniscenko, Nathan W Bartlett, Michael R Edwards, Sebastian L Johnston, Aran Singanayagam

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. How inhaled corticosteroids target inflammation in COPD.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Faisal KamalNational Heart and Lung Institute, Imperial College, London, UK.
Nicholas GlanvilleNational Heart and Lung Institute, Imperial College, London, UK.
Wangmingyu XiaNational Heart and Lung Institute, Imperial College, London, UK.
Eteri BakhsolianiNational Heart and Lung Institute, Imperial College, London, UK.
Julia AniscenkoNational Heart and Lung Institute, Imperial College, London, UK.
Nathan W BartlettFaculty of Health and Medicine and Priority Research Centre for Healthy Lungs, University of Newcastle, Australia.
Michael R EdwardsNational Heart and Lung Institute, Imperial College, London, UK.
Sebastian L JohnstonNational Heart and Lung Institute, Imperial College, London, UK.
Aran SinganayagamNational Heart and Lung Institute, Imperial College, London, UK. Electronic address: a.singanayagam@imperial.ac.uk.
Imperial College London · GBUniversity of Newcastle Australia · AU

Funding

Wellcome TrustWellcome Trust WT096382AIA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, InhalationAnimalsAnti-Inflammatory AgentsBeclomethasoneBudesonideDisease SusceptibilityFemaleFluticasoneMiceMice, Inbred C57BLPneumonia, PneumococcalPulmonary Disease, Chronic ObstructiveStreptococcus pneumoniaeAnti-Inflammatory AgentsBeclomethasoneBudesonideFluticasone

Identifiers

PMID32454043
PMCPMC7476496
OpenAlexW3028436650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.